Qiagen N.V. (QGEN) Q2 2025 Earnings Call Transcript

2025-08-06 13:44:38 ET

Qiagen N.V. (QGEN)

Q2 2025 Earnings Conference Call

August 06, 2025, 09:30 AM ET

Company Participants

John Gilardi - Vice President of Corporate Communications & Investor Relations

Roland Sackers - CFO, MD & Member of Management Board

Thierry Bernard - CEO, MD & Member of Management Board

Conference Call Participants

Aisyah Noor - Morgan Stanley, Research Division

Casey Rene Woodring - JPMorgan Chase & Co, Research Division

Daniel Gregory Brennan - TD Cowen, Research Division

Daniel Louis Leonard - UBS Investment Bank, Research Division

Douglas Anthony Schenkel - Wolfe Research, LLC

Harry MacKinnon Gillis - Joh. Berenberg, Gossler & Co. KG, Research Division

Hugo Solvet - BNP Paribas Exane, Research Division

Jack Meehan - Nephron Research LLC

Jan Koch - Deutsche Bank AG, Research Division

Michael Leonidovich Ryskin - BofA Securities, Research Division

Salem Salem - Barclays Bank PLC, Research Division

Tycho W. Peterson - Jefferies LLC, Research Division

Presentation

Operator

Ladies and gentlemen, thank you for standing by. I am Katie, your Global Meet call operator. Welcome, and thank you for joining QIAGEN'S Q2 2025 Earnings Conference Call Webcast. [Operator Instructions] Please be advised that this call is being recorded at QIAGEN's request and will be made available on their Internet site. [Operator Instructions] At this time, I'd like to introduce your host, John Gilardi, Vice President, Head of Corporate Communications at QIAGEN. Please go ahead.

John Gilardi

Thank you, operator, and welcome to all of you to our call today for the second quarter of 2025. We appreciate your time and interest in QIAGEN....

Read the full article on Seeking Alpha

For further details see: